Filemon S Dela Cruz

Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven Cancer.

Andrea Califano, Stephen S Roberts, Ryma Benayed, 2019, Cancer discovery.

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

Paul A Clemons, Andrea Califano, Mariano J. Alvarez, 2018, Nature Genetics.